MonumenTAL-1
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Experimental Part 3, Cohort A:Talquetamab (No Prior T Cell Redirection Therapies)
Accepting patients
Experimental Part 3, Cohort B:Talquetamab (Prior T Cell Redirection Therapies)
Accepting patients
Experimental Part 3, Cohort C:Talquetamab Bi-Weekly
Accepting patients
Experimental Part 3, Cohort D:Talquetamab
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.